معرفی
Rémi Rabasa-Lhoret is a Full Professor at the University of Montreal's Faculty of Medicine and Director of the Metabolic Diseases Research Unit and Diabetes Clinic at the Montreal Clinical Research Institute (IRCM). He is a leading expert in diabetes, particularly Type 1 Diabetes and Cystic Fibrosis-Related Diabetes, with a focus on Artificial Pancreas Systems, Hypoglycemia Prevention, and Metabolic Health.
- Key Affiliations: University of Montreal, IRCM, CHUM, Canadian Network for Aging Research
- Research Themes: Glucose Control in Diabetes, Obesity Metabolism, Exercise Endocrinology, Cystic Fibrosis Complications
His recent work explores once-weekly semaglutide for type 2 diabetes management, carbohydrate strategies in exercise for type 1 diabetes, and HbA1c validation for early cystic fibrosis-related diabetes screening. He investigates metabolic syndrome in postmenopausal women and fat-free mass dynamics in obesity.
Scientific Recognition:
- 2021 Canadian Academy of Health Sciences Fellow
- 2017 FMSQ Research Award
- 2016 IMS Brogan Prize
- Three consecutive Excellence in Teaching Awards (2012-2014)
His 15 most recent publications (2021-2021) span diabetes technology (artificial pancreas systems), nutrition interventions (caloric restriction trials), metabolic disease mechanisms in cystic fibrosis, and obesity management in aging populations. Key subfields include glycemia monitoring, exercise endocrinology, insulin delivery algorithms, and cardiometabolic risk assessment.
As a research supervisor, he mentors graduate students in clinical diabetes research and collaborates with multidisciplinary teams at IRCM. His work receives funding from NIH, CIHR, Diabetes Canada, and Cystic Fibrosis Canada.